Modulating the natural history of type 1 diabetes in children at high genetic risk by mucosal insulin immunization (Q37150497)

18 August 2017

1 reference

title

Modulating the natural history of type 1 diabetes in children at high genetic risk by mucosal insulin immunization (English)

1 reference

18 August 2017

0 references

0 references

1 reference

2

Jennifer Barker

1 reference

18 August 2017

Peter Achenbach

1

1 reference

PubMed ID

18445349

18 August 2017

Ezio Bonifacio

series ordinal

3

1 reference

PubMed ID

18445349

18 August 2017

Pre-POINT Study Group

series ordinal

4

1 reference

18 August 2017

1 April 2008

1 reference

18 August 2017

Current diabetes report

1 reference

18 August 2017

8

1 reference

18 August 2017

2

1 reference

18 August 2017

87-93

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-008-0017-y

18 August 2017

0 references

cites work

Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice

1 reference

https://api.crossref.org/works/10.1007%2FS11892-008-0017-Y

Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-008-0017-Y

Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-008-0017-Y

Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-008-0017-Y

Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes

21 January 2018

1 reference

12 December 2020

Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope

1 reference

12 December 2020

Effects of insulin in relatives of patients with type 1 diabetes mellitus

1 reference

12 December 2020

Effects of oral administration of type II collagen on rheumatoid arthritis

1 reference

12 December 2020

Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse

1 reference

12 December 2020

Antigen-specific therapy for autoimmune disease

1 reference

12 December 2020

Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice

1 reference

12 December 2020

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus

1 reference

12 December 2020

Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes

1 reference

12 December 2020

Cytokine profile and insulin antibody IgG subclasses in patients with recent onset Type 1 diabetes treated with oral insulin

1 reference

12 December 2020

Extreme genetic risk for type 1A diabetes

1 reference

12 December 2020

Effect of oral insulin on insulin autoantibody levels in the Diabetes Prevention Trial Type 1 oral insulin study

1 reference

12 December 2020

Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation

1 reference

12 December 2020

The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study

1 reference

12 December 2020

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

1 reference

12 December 2020

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study

1 reference

12 December 2020

Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.

1 reference

12 December 2020

Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study

1 reference

12 December 2020

IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity.

1 reference

12 December 2020

Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes

1 reference

12 December 2020

Insulin-specific tolerance in diabetes

1 reference

12 December 2020

Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin

1 reference

12 December 2020

Standardization of T-cell assays in Type I diabetes. Immunology of Diabetes Society T-cell Committee

1 reference

12 December 2020

1 reference

12 December 2020

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

1 reference

12 December 2020

Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.

1 reference

12 December 2020

Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes

1 reference

12 December 2020

Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice

1 reference

12 December 2020

Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects

1 reference

12 December 2020

Association of non-HLA genes with type 1 diabetes autoimmunity

1 reference

12 December 2020

Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes

1 reference

12 December 2020

European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes

1 reference

12 December 2020

Intranasally administered insulin intended for prevention of type 1 diabetes--a safety study in healthy adults

1 reference

12 December 2020

Active suppression of diabetes after oral administration of insulin is determined by antigen dosage

1 reference

12 December 2020

Therapeutic potential of oral tolerance

1 reference

12 December 2020

Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes

1 reference

12 December 2020

Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.

1 reference

12 December 2020

Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.

1 reference

12 December 2020

IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes

1 reference

12 December 2020

Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial Group

1 reference

12 December 2020

Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes

1 reference

12 December 2020

Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice

1 reference

12 December 2020

Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).

1 reference

12 December 2020

Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population

1 reference

12 December 2020

Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age

1 reference

12 December 2020

Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse

1 reference

12 December 2020

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

1 reference

12 December 2020

Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

1 reference

12 December 2020

Islet autoimmunity in infants with a Type I diabetic relative is common but is frequently restricted to one autoantibody

1 reference

12 December 2020

The human leukocyte antigen genotype has a modest effect on the insulin gene polymorphism-associated susceptibility to type 1 diabetes in the Finnish population

1 reference

12 December 2020

10.1007/S11892-008-0017-Y

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18445349